name
CellGenix® Recombinant Human Transforming Growth Factor-beta 1
Source
CAP® cell line
Formulation
Lyophilized
ANIMAL-DERIVED COMPONENT-FREE
CellGenix® GMP rh TGF-β1
amount
Order Number
50  µg
1026-050
CellGenix® Preclinical rh TGF-β1
amount
Order Number
50  µg
1426-050

CellGenix® rh TGF-β1

Features

  • Native folding & glycosylation: expressed in human CAP® cells
  • Safe and ADCF: CAP® cell line extensively characterized and tested for viruses
  • Global compliance: USP <1043>, Ph. Eur. 5.2.12, ISO 20399:2022
  • FDA Drug Master File available (GMP)

GMP & Preclinical Grade

  • Seamless transition from preclinical development to ATMP manufacturing

Applications

  • Differentiation of T cells into Tregs
  • Expansion of ESCs, iPSCs, MSCs and Tregs

Highest GMP Quality Standard

  • High lot-to-lot consistency – save time and costs on revalidations
  • Performance reliability – rely on consistent product performance
  • Highest purity – ensure the safety of your ATMP
  • Extremely low endotoxin levels – improve safety and reproducibility
  • Expert regulatory & technical support – rely on experience

Read more about our GMP Quality

 

Safe │ GMP Compliant │ Reliable

Technical Details

Source
Expressed in CAP® cell line
Description

Human Transforming Growth Factor-beta 1, accession # PO1137, Ala279-Ser390

Formulation

Lyophilized from a 0.2 µm-filtered solution containing 1% Mannitol

The production cell line was derived from an extensively characterized human amniocyte cell line (CAP®).
CAP® is a registered trademark of CEVEC Pharmaceuticals GmbH, Germany.

  Preclinical GMP
Starting Material

CAP® MCB characterized according to ICH Guidelines Q5A and Q5D
Biologics Master File (BB-MF) for the originating CAP® cell bank available

CAP® MCB characterized according to ICH Guidelines Q5A and Q5D
Biologics Master File (BB-MF) for the originating CAP® cell bank available

Molecular weight 25.6 kDa per homodimer 25.6 kDa per homodimer
Purity ≥ 95% as determined by SDS-PAGE ≥ 97% as determined by SDS-PAGE
Activity

≥ 9 x 106 IU/mg, calibrated against NIBSC #89/514
Measured in a cell proliferation assay using a TGF-β1-dependent cell line, HT2 clone A5E

 

≥ 9 – 36 x 106 IU/mg, calibrated against NIBSC #89/514
Measured in a cell proliferation assay using a TGF-β1-dependent cell line, HT2 clone A5E

Batch specific activity on CoA

Endotoxin level ≤ 10 EU/mg ≤ 10 EU/mg
Intended use Intended for preclinical ex vivo use. Not intended for therapeutic use. For further manufacturing use.

Handling Instructions

Reconstitution

Recommended in sterile water to a final concentration of 250 µg/ml.

Shipment

Ambient temperature. Please refer to our Technote Shipment of CellGenix® Preclinical and GMP Cytokines at Ambient Temperatures.

Expiry

Please refer to Certificate of Analysis for the exact expiry date.

Storage & Stability

Store lyophilized cytokine at -20°C to -80°C.

Avoid repeated freeze/thaw cycles.

Documents

Data

CellGenix® GMP rh TGF-β1 has an activity of 9 – 36 x 106 IU/mg

The activity of GMP rh TGF-β1 was measured in a cell proliferation assay using the TGF-dependent cell line HT2-clone A5E. It was calibrated against the WHO International Standard NIBSC #89/514.

You can find the batch specific activity on the Certificate of Analysis (CoA).

Regulatory Support

We offer the following to assist you with your regulatory approval process:

  • Comprehensive documentation (e.g. DMFs, Regulatory Support Files, Certificates of Origin)
  • Outstanding QC support (e.g. extensive stability data)
  • The possibility to audit our production site
  • Detailed batch specific test results on our Certificates of Analysis
  • Change notifications prior to relevant changes

Customized solutions can be provided to meet special compliance needs. Contact our Regulatory Support Team for all your regulatory requests & questions:

Phone:     +49 761 88 88 9-0
Email:      regulatorysupport@cellgenix.com

 

In order to stay up-to-date and help improve regulatory guidance we are actively involved in many of the regulatory initiatives and discussions. We were amongst others actively involved in the discussions for the setup of Ph. Eur. General Chapter 5.2.12 and ISO 20399:2022.

 

Regulatory Resources

  • TSE certificate (available on request)
  • Regulatory Support File (available on request)
  • Request a DMF Letter of Authorization (USA only)

Title

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

We are happy to send the requested document to your email address:

Would you like to be the first to receive the latest news, documents, product updates and tips from Sartorius CellGenix?


You can unsubscribe at any time by sending an email to info@cellgenix.com or by using the unsubscribe option at the bottom of our newsletters and emails.
×

Where are you located?

Note: You have to select a country.